Apimeds Pharmaceuticals US (APUS) Notes Payables (2023 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Notes Payables came in at $7.1 million in Q4 2025, up 2736.51% YoY from $250000.0 in Q4 2024, and up 2736.51% on a QoQ basis from $250000.0 in Q1 2025.
Apimeds Pharmaceuticals US (APUS) Notes Payables (2023 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 3 years of Notes Payables data on file, last reported at $7.1 million in Q4 2025.
- Quarterly Notes Payables rose 2736.51% year-over-year to $7.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.1 million (up 2736.51% YoY) and the FY2025 annual result came in at $7.1 million, up 2736.51% from the prior year.
- Notes Payables advanced to $7.1 million in Q4 2025, from $250000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $7.1 million in Q4 2025 to a low of $250000.0 in Q4 2024.
- A 3-year average of $2.0 million and a median of $258445.5 in 2023 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2024 — Notes Payables decreased 6.33% — and 2025, when it soared 2736.51%.
- Tracing APUS's Notes Payables over 3 years: stood at $266891.0 in 2023, then fell by 6.33% to $250000.0 in 2024, then soared by 2736.51% to $7.1 million in 2025.
- The last three Notes Payables figures came in at $7.1 million (Q4 2025), $250000.0 (Q1 2025), and $250000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Apimeds Pharmaceuticals US | 7.12 Mn | 7.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.09 Mn |
| Mar 31, 2025 | 250,000.00 |
| Dec 31, 2024 | 250,000.00 |
| Dec 31, 2023 | 266,891.00 |